3062 Ceritinib following crizotinib in ALK-positive (+) advanced NSCLC patients (pts): Results from the French Temporary Authorization for Use (ATU) experience. (September 2015)

Record Type:: Journal Article
Title:: 3062 Ceritinib following crizotinib in ALK-positive (+) advanced NSCLC patients (pts): Results from the French Temporary Authorization for Use (ATU) experience. (September 2015)
Main Title:: 3062 Ceritinib following crizotinib in ALK-positive (+) advanced NSCLC patients (pts): Results from the French Temporary Authorization for Use (ATU) experience
Authors:: Cadranel, J.
Cortot, A.
Lena, H.
Mennecier, B.
Do, P.
Dansin, E.
Mazieres, J.
Chouaid, C.
Perol, M.
Barlesi, F.
Abstract:
Is Part Of:: European journal of cancer. Volume 51:(2015)Supplement 3
Journal:: European journal of cancer
Issue:: Volume 51:(2015)Supplement 3
Issue Display:: Volume 51, Issue 3 (2015)
Year:: 2015
Volume:: 51
Issue:: 3
Issue Sort Value:: 2015-0051-0003-0000
Page Start:: S616
Page End:: S617
Publication Date:: 2015-09
Subjects:: Cancer -- Periodicals
Neoplasms -- Periodicals
Cancer -- Périodiques
Cancer
Tumors
Electronic journals
Periodicals
Electronic journals
616.994
Journal URLs:: http://www.sciencedirect.com/science/journal/09598049 ↗
http://rzblx1.uni-regensburg.de/ezeit/warpto.phtml?colors=7&jour_id=2879 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/09598049 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/09598049 ↗
http://www.elsevier.com/journals ↗
DOI:: 10.1016/S0959-8049(16)31704-X ↗
Languages:: English
ISSNs:: 0959-8049
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 3829.725100
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:: 2034.xml